Back to top

hmo: Archive

Kaibalya Pravo Dey

UnitedHealth Reaffirms 2025 EPS Guidance: Time to Buy or Wait?

UNH reaffirms its 2025 EPS outlook, but mounting costs, legal probes and valuation pressures cloud the path ahead.

UNHPositive Net Change BRK.BNegative Net Change MOHPositive Net Change CNCPositive Net Change

Zacks Equity Research

Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBHPositive Net Change

Kaibalya Pravo Dey

UNH or ELV: Which Healthcare Titan Will Regain Investor Trust First?

UnitedHealth and Elevance battle rising costs, but scale, Optum, and Buffett's backing give UNH the edge in restoring investor trust.

UNHPositive Net Change ELVPositive Net Change